These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19194846)

  • 1. [Acquired stuttering in a psychotic patient].
    Klein Hofmeijer-Sevink M; van Eijk ZJ; van der Zwaard R
    Tijdschr Psychiatr; 2009; 51(1):53-7. PubMed ID: 19194846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine for the treatment of acquired neurogenic stuttering.
    Catalano G; Robben DL; Catalano MC; Kahn DA
    J Psychiatr Pract; 2009 Nov; 15(6):484-8. PubMed ID: 19934725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine- and clozapine-induced stuttering. A case series.
    Bär KJ; Häger F; Sauer H
    Pharmacopsychiatry; 2004 May; 37(3):131-4. PubMed ID: 15179972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case Report of Stuttering Induced by Risperidone and Chlorpromazine.
    Sood S
    Psychopharmacol Bull; 2022 Feb; 52(1):53-56. PubMed ID: 35342201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
    Keefe RS; Seidman LJ; Christensen BK; Hamer RM; Sharma T; Sitskoorn MM; Lewine RR; Yurgelun-Todd DA; Gur RC; Tohen M; Tollefson GD; Sanger TM; Lieberman JA
    Am J Psychiatry; 2004 Jun; 161(6):985-95. PubMed ID: 15169686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine vs haloperidol for treatment of schizophrenia.
    Amin M; Shukla VS
    JAMA; 2004 Mar; 291(9):1065; author reply 1065-6. PubMed ID: 14996767
    [No Abstract]   [Full Text] [Related]  

  • 7. Risperidone induced stuttering.
    Yadav DS
    Gen Hosp Psychiatry; 2010; 32(5):559.e9-10. PubMed ID: 20851282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine vs haloperidol for treatment of schizophrenia.
    Glazer WM
    JAMA; 2004 Mar; 291(9):1064-5; author reply 1065-6. PubMed ID: 14996766
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
    Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
    J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine-induced stuttering: a case report and analysis of similar case reports in the literature.
    Grover S; Verma AK; Nebhinani N
    Gen Hosp Psychiatry; 2012; 34(6):703.e1-3. PubMed ID: 22516217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine treatment of eight adolescent patients with psychosis.
    Ercan ES; Kutlu A; Varan A; Cikoğlu S; Coşkunol H; Bayraktar E
    Hum Psychopharmacol; 2004 Jan; 19(1):53-6. PubMed ID: 14716713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia.
    Hempel RJ; Tulen JH; van Beveren NJ; Röder CH; Hengeveld MW
    J Psychopharmacol; 2009 Aug; 23(6):697-707. PubMed ID: 18562420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuation of risperidone, olanzapine, and haloperidol in first-episode psychosis.
    Shim JC; Choe BM; Kim JG; Jae YM; Kim HC; Kim SG; Oh MK; Kelly DL; Conley RR
    J Clin Psychopharmacol; 2007 Aug; 27(4):400-1. PubMed ID: 17632229
    [No Abstract]   [Full Text] [Related]  

  • 15. Olanzapine-associated pica in a schizophrenia patient.
    Huang JH; Shiah IS; Lee WK; Tzang RF; Chang KJ
    Psychiatry Clin Neurosci; 2010 Aug; 64(4):444. PubMed ID: 20653915
    [No Abstract]   [Full Text] [Related]  

  • 16. Olanzapine and haloperidol in first episode psychosis: two-year data.
    Green AI; Lieberman JA; Hamer RM; Glick ID; Gur RE; Kahn RS; McEvoy JP; Perkins DO; Rothschild AJ; Sharma T; Tohen MF; Woolson S; Zipursky RB;
    Schizophr Res; 2006 Sep; 86(1-3):234-43. PubMed ID: 16887334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-onset cholestatic hepatitis induced by olanzapine in a patient with schizophrenia.
    Hung CC; Wei IH; Huang CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1574-5. PubMed ID: 19766687
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation.
    Villari V; Rocca P; Fonzo V; Montemagni C; Pandullo P; Bogetto F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):405-13. PubMed ID: 17900775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study.
    Alptekin K; Hafez J; Brook S; Akkaya C; Tzebelikos E; Ucok A; El Tallawy H; Danaci AE; Lowe W; Karayal ON
    Int Clin Psychopharmacol; 2009 Sep; 24(5):229-38. PubMed ID: 19531959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible olanzapine-induced hepatotoxicity in a young Chinese patient.
    Lui SY; Tso S; Lam M; Cheung EF
    Hong Kong Med J; 2009 Oct; 15(5):394-6. PubMed ID: 19801701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.